Acesso livre
Acesso livre

Infectologia

Perspectiva | Consequências da COVID-19 para o sistema nervoso.

21 Jan, 2022 | 15:57h

Nervous system consequences of COVID-19 – Science

Conteúdos relacionados:

Perspective | Post-acute neurological consequences of COVID-19: an unequal burden – “COVID-19 and its neurological consequences particularly burden marginalized communities, and so can only be effectively treated by advancing health equity”.

Review: Counting the neurological cost of COVID-19.

Infection with Covid-19 carries a much higher risk of developing neurological complications than Covid-19 vaccines.

M-A: Frequency of Neurologic Manifestations in COVID-19 – up to one-third of patients (89% hospitalized) experienced at least one neurological manifestation.

Neurological Effects of COVID-19 in Children.

Cohort study: Neurological manifestations of SARS-CoV-2 infection in hospitalized children and adolescents in the UK – “around 1 in 20 of children hospitalized with COVID-19 develop brain or nerve complications linked to the viral infection”.

International Registry: Ischemic and hemorrhagic stroke among critically ill patients with Covid-19.

Short review: Neurological complications of COVID-19.

2 new meta-analysis detail neurologic and psychiatric conditions in COVID-19.

M-A: Encephalitis as Neurological Complication of COVID‐19.

Large study finds 1 in 3 Covid-19 survivors have subsequent mental health and neurological conditionsEight out of ten people hospitalized with COVID-19 develop neurological problems – the most common self-reported symptoms included headache (37%) and anosmia or ageusia (26%).

[Preprint] Frequency of neurological manifestations in COVID-19: a systematic review and meta-analysis of 350 studies – up to one-third of COVID-19 patients analyzed in this review, 89% of whom were hospitalized, experienced at least one neurological manifestation

 

Comentário no Twitter

 

Revisão | Avaliação pós-alta de indivíduos internados com COVID-19.

21 Jan, 2022 | 15:56h

Postdischarge Evaluation for Individuals Hospitalized with COVID-19 – Southern Medical Journal

[Preprint] Gravidade da infecção por COVID em crianças com menos de 5 anos antes e depois do surgimento da variante Ômicron nos EUA.

21 Jan, 2022 | 15:54h

COVID infection severity in children under 5 years old before and after Omicron emergence in the US – medRxiv

Comentário: SARS-CoV-2 Omicron infections milder in children compared to Delta – News Medical

Grupo de especialistas em emergências da OMS reafirma posição contra os “passaportes de vacina” para viagens internacionais.

21 Jan, 2022 | 15:53h

WHO’s Emergencies Expert Group Re-Asserts Stance Against COVID ‘Vaccine Passports’ for International Travel – Health Policy Watch

Editorial | Vacinas contra Covid-19 e tratamentos: devemos ter os dados brutos, agora.

21 Jan, 2022 | 15:52h

Covid-19 vaccines and treatments: we must have raw data, now – The BMJ

Comunicado de imprensa: Editors call for covid-19 vaccine and treatment data to be available for public scrutiny – The BMJ

Editorial | “Long covid” em crianças e adolescentes – “O risco parece baixo, mas muitas questões permanecem.”

21 Jan, 2022 | 15:51h

Long covid in children and adolescents – The BMJ

Conteúdos relacionados:

M-A: Persistent symptoms following SARS-CoV-2 infection among children and young people – “Higher study quality was associated with lower prevalence of all symptoms, except loss of smell and cognitive symptoms”.

Review: Long COVID symptoms in children rarely persist beyond three months.

Cohort study: long term follow-up showed most patients with post–COVID-19 Multisystem Inflammatory Syndrome in Children had good outcomes with no significant medium- or long-term sequelae.

Long COVID: the physical and mental health of children and non-hospitalized young people after SARS-CoV-2 infection – one in seven children may still have symptoms 15 weeks after infection.

Do kids get long COVID? And how often? A pediatrician looks at the data – Children also get Long Covid, but much less often than adults.

Illness duration and symptom profile in symptomatic school-aged children tested for SARS-CoV-2 – “Only 25 (1.8%) of 1379 children experienced symptoms for at least 56 days.”

Long-term Symptoms After SARS-CoV-2 Infection in Children and Adolescents – “This study found a low prevalence of symptoms compatible with long COVID in a randomly selected cohort of children assessed 6 months after serologic testing”.

Study shows low incidence of post-acute COVID-19 symptoms (“Long Covid”) in children after mild disease

Cohort study: Risk factors for long covid in previously hospitalized children.

M-A: More than 50 long-term effects of COVID-19.

 

Comentário no Twitter

 

Estudo de coorte | Entre pacientes com hepatite B resolvida e doenças autoimunes concomitantes, a exposição a doses de prednisona maiores que 20 mg/dia foi associada com alto risco para reativação do vírus da hepatite B (VHB) ou surto de hepatite.

21 Jan, 2022 | 15:39h

Average corticosteroid dose and risk for HBV reactivation and hepatitis flare in patients with resolved hepatitis B infection – Annals of Rheumatic Disease (link para o resumo – $ para o texto completo)

 

Comentário no Twitter

 

M-A | Não há diferença nos desfechos com monoterapia com betalactâmico vs. terapia combinada nas infecções de corrente sanguínea ou pneumonia por P. aeruginosa.

21 Jan, 2022 | 15:37h

Beta-lactam monotherapy or combination therapy for bloodstream infections or pneumonia due to P. aeruginosa: a meta-analysis – International Journal of Antimicrobial Agents (link para o resumo – $ para o texto completo)

Longevidade do reforço: dados revelam quanto tempo dura a proteção da terceira dose.

20 Jan, 2022 | 23:19h

Booster longevity: Data reveals how long a third shot protects – NPR

Relatório original: SARS-CoV-2 variants of concern and variants under investigation in England – U.K. Health Security Agency

Estudo de coorte retrospectiva de base populacional no Catar mostrou menor risco de infecção por Covid-19 após a vacina da Moderna em comparação com a da Pfizer–BioNTech.

20 Jan, 2022 | 23:17h

Effectiveness of mRNA-1273 and BNT162b2 Vaccines in Qatar – New England Journal of Medicine

 

Comentário no Twitter

 

Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.